These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 27593968

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Sensitivity analyses of unmeasured and partially-measured confounders using multiple imputation in a vaccine safety study.
    Xu S, Clarke CL, Newcomer SR, Daley MF, Glanz JM.
    Pharmacoepidemiol Drug Saf; 2021 Sep; 30(9):1200-1213. PubMed ID: 33988275
    [Abstract] [Full Text] [Related]

  • 24. Methodologic challenges to studying patient safety and comparative effectiveness.
    Strom BL.
    Med Care; 2007 Oct; 45(10 Supl 2):S13-5. PubMed ID: 17909371
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Osteopathic manipulative treatment: A systematic review and critical appraisal of comparative effectiveness and health economics research.
    Steel A, Sundberg T, Reid R, Ward L, Bishop FL, Leach M, Cramer H, Wardle J, Adams J.
    Musculoskelet Sci Pract; 2017 Feb; 27():165-175. PubMed ID: 27852531
    [Abstract] [Full Text] [Related]

  • 31. Martingale residual-based method to control for confounders measured only in a validation sample in time-to-event analysis.
    Burne RM, Abrahamowicz M.
    Stat Med; 2016 Nov 10; 35(25):4588-4606. PubMed ID: 27306611
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making.
    Etminan M, Gill S, Fitzgerald M, Samii A.
    J Clin Pharmacol; 2006 Jan 10; 46(1):6-9. PubMed ID: 16397278
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Bias Analysis for Uncontrolled Confounding in the Health Sciences.
    Arah OA.
    Annu Rev Public Health; 2017 Mar 20; 38():23-38. PubMed ID: 28125388
    [Abstract] [Full Text] [Related]

  • 40. Revisiting the washout period in the incident user study design: why 6-12 months may not be sufficient.
    Roberts AW, Dusetzina SB, Farley JF.
    J Comp Eff Res; 2015 Jan 20; 4(1):27-35. PubMed ID: 25565067
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.